About WHO

Priority evaluations

Ebola Interim Assessment

In 2015, a major focus of the work of the Evaluation Office was to support the work of the Ebola Interim Assessment Panel established in response to resolution EBSS3.R1, adopted during the special session of the Executive Board in January 2015. The Panel submitted its first report to the Sixty-eighth World Health Assembly, and the final report was delivered in July 2015. The Secretariat issued its response to the Panel’s report in August 2015. The Panel’s recommendations further informed the work of the United Nations Secretary General’s High-Level Panel on the Global Response to Health Crises, the deliberations of the Review Committee on the Role of the International Health Regulations (2005) in the Ebola Outbreak and Response and the Director-General’s Advisory Group on Reform of WHO’s work in Outbreaks and Emergencies with Health and Humanitarian Consequences.

WHO Presence in countries

The aim of the evaluation of WHO’s presence in countries was to assess the Secretariat’s contribution to the delivery of Organization-wide outcomes and the attainment of country-level goals. This evaluation addressed the following high-level questions:

  • What does WHO’s presence in countries mean and does it respond to Member States’ and other relevant partners’ expectations?
  • What is the contribution of WHO’s presence in countries to addressing global and individual countries’ health priorities and needs?
  • What is WHO’s added value at country level in the light of its level of investment?
  • What are the modalities for strengthening or reducing WHO’s presence in countries based on the different health status and needs of individual countries?
  • To what extent does WHO exert effective leadership and convening capacity at country level to mobilize different stakeholders and act as a broker of partnerships in support of the national health and development agenda?

Comprehensive Evaluation of the Implementation of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property

  • The global strategy on public health, innovation and intellectual property aims to promote new thinking on innovation and access to medicines and, based on the recommendations of the report of the Commission on Intellectual Property Rights, Innovation and Public Health, provide a medium-term framework for securing an enhanced and sustainable basis for needs-driven essential health research and development relevant to diseases that disproportionately affect developing countries, proposing clear objectives and priorities for research and development, and estimating funding needs in this area.
  • The overall purpose of the comprehensive evaluation is to assess the status of implementation of the eight elements of the global strategy: (a) prioritizing research and development needs; (b) promoting research and development; (c) building and improving innovative capacity; (d) transfer of technology; (e) application and management of intellectual property to contribute to innovation and promote public health; (f) improving delivery and access; (g) promoting sustainable financing mechanisms; and (h) establishing monitoring and reporting systems.
  • Covering the period 2008–2015, the evaluation will document achievements, gaps and remaining challenges and make recommendations on the way forward. It will also inform the overall programme review.
  • The scope of the evaluation will cover implementation of the eight elements of the strategy itself and the 108 specific actions defined in the action plan. It will look at such implementation by all stakeholders listed in the action plan at different levels (global, regional and national), including looking at implementation by national governments, the WHO Secretariat and other relevant stakeholders.
  • This evaluation is envisaged as a formative evaluation conducted during the implementation phase of the global strategy and plan of action, with the intention of documenting achievements, gaps and remaining challenges and of making recommendations on the way forward.

Impact of WHO publications

The overall purpose of the evaluation of the impact of WHO publications was to assess the impact of WHO publications by considering the reach, usefulness and use of a representative sample of WHO information products as estimates for their impact. Specifically, it addressed the following high-level questions:

  • To what extent do WHO publications reach their intended audiences and what are their major gaps in reach and why did the latter arise?
  • What is the perceived usefulness of WHO publications (by information product type)?
  • To what extent are WHO publications used as references and as authoritative sources of information for decision-making in clinical, public health and policy-making contexts?
  • What is the extent of implementation of WHO’s publications policy and its influence in the impact of WHO publications?

FAO/WHO Project and Fund for Enhanced Participation in Codex (Codex Trust Fund) Final Project Evaluation, 2015

The evaluation of the FAO/WHO Project and Fund for Enhanced Participation in the Codex Trust Fund was completed and the final report was discussed at the 38th session of the Codex Alimentarius Commission in July 2015. The administrator of the Codex Trust Fund in the WHO Secretariat managed the evaluation, and the FAO/WHO Consultative Group for the Trust Fund was the ad hoc evaluation management group, with technical backstopping and quality assurance provided by the Evaluation Office.

WFP/FAO/UNICEF/WHO/DFATD Canada Joint Evaluation of Renewed Effort Against Child Hunger and Under-nutrition (REACH): A Strategic Evaluation

The Evaluation Office also supports or jointly manages a number of other evaluation exercises, both in WHO and with other partners. The latter include a joint United Nations evaluation of the United Nations REACH Partnership, commissioned by the WFP Office of Evaluation, with WHO as a member of the evaluation management group. The final report of the evaluation was presented at the WFP Executive Board meeting in November 2015.